Print Page     Close Window     

SEC Filings

20-F
AC IMMUNE SA filed this Form 20-F on 03/21/2019
Entire Document
 

Exhibit 4.15

 

EXECUTION VERSION

 

CONVERTIBLE NOTE AGREEMENT

 

(the “Note Agreement”) dated 11 December 2018

made by and among

 

 

 

Eli Lilly and Company

 

Lilly Corporate Center, Indianapolis, IN 46285, U.S.A.

 

(the “Lender”)

 

 

 

and

 

 

 

AC Immune SA

 

EPFL Innovation Park Building B, 1015 Lausanne, Switzerland

 

 

 

(the “Borrower” or “Company”)

 

(the Lender and the Company, the “Parties” and each a “Party”)

 

 

 

with respect to a convertible loan granted to the Company

 

 


© AC Immune 2015